NASDAQ$ILMN

Illumina · Q1 2020 earnings

Q1 2020 earnings · · Investor relations

Briefing

Reported financial results for the first quarter of fiscal year 2020.

Illumina's first quarter 2020 revenue increased by 2% to $859 million compared to $846 million in the first quarter of 2019. GAAP net income attributable to Illumina stockholders was $173 million, or $1.17 per diluted share, compared to $233 million, or $1.57 per diluted share, for the first quarter of 2019. Non-GAAP net income attributable to Illumina stockholders was $243 million, or $1.64 per diluted share, compared to $237 million, or $1.60 per diluted share, for the first quarter of 2019.

  • Revenue of $859 million, a 2% increase compared to the first quarter of 2019.
  • GAAP net income attributable to Illumina stockholders for the quarter of $173 million, or $1.17 per diluted share.
  • Non-GAAP net income attributable to Illumina stockholders for the quarter of $243 million, or $1.64 per diluted share.
  • Free cash flow of $241 million for the quarter compared to $142 million in the first quarter of 2019.

Headline financials

Total Revenue

$859M

Previous: $846M+1.5%
EPS (adj)

$1.64

Previous: $1.60+2.5%
GAAP Gross Margin

72.1%

Previous: 69.1%+4.3%
Non-GAAP Gross Margin

73.0%

Previous: 70.2%+4.0%
Capital Expenditures

-$40M

Previous: -$56M+28.6%
Free Cash Flow

$133M

Previous: $177M-24.9%
Net Income

$173M

Previous: $233M-25.8%
Operating Income

$189M

Previous: $204M-7.4%
Gross Profit

$619M

Previous: $584M+6.0%
Cash & Equivalents

$1.99B

Previous: $2.27B-12.3%
Total Assets

$7.26B

Previous: $7.39B-1.7%
Stock-Based Comp

$39M

Previous: $51M-23.5%

Revenue & EPS history

Illumina · Revenue · Quarterly

$859M

Q1 2020+1.5%vs Q1 2019
Beat estimate in 14 of 16 quarters(88%)
ActualEstimate

Revenue by segment

Illumina · $147M total across 1 segment · Q1 2023

  • Service and Other Revenue
    $147M+5.0%

Forward guidance

Illumina has withdrawn its fiscal 2020 full year revenue and earnings per share guidance due to the COVID-19 pandemic.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2020

Historical avgQ1 2020

-0.8%

Avg return

Earnings day

-1.7%

Avg return

5 days after

-0.7%

Avg return

30 days after

35%

22 / 63 earnings

Positive

+21.1%

Q3 2025

Best reaction

-19.1%

Q1 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+2.3%+12.5%+28.5%
Q4 2025-10.4%-12.9%-6.7%
Q3 2025+21.1%+23.7%+32.8%
Q1 2025-4.9%-1.7%+3.9%
Q3 2024+3.5%+0.9%-4.8%
Q2 2024+4.9%+7.0%+12.4%
Q1 2024-5.4%-9.5%-16.4%
Q4 2023-3.6%-6.4%-5.3%
Q3 2023-11.1%-11.9%+2.0%
Q2 2023-0.6%-5.9%-14.9%
Q1 2023-7.9%-10.3%-15.5%
Q4 2022-4.9%-5.8%-2.9%
Q3 2022+6.3%+3.3%+3.7%
Q2 2022-8.3%-3.3%-7.5%
Q1 2022-19.1%-28.6%-24.3%
Q4 2021-10.0%-7.0%-17.4%
Q3 2021-2.7%-5.8%-17.2%
Q2 2021-1.5%+0.4%-7.5%
Q1 2021-3.6%-6.6%-2.8%
Q4 2020+12.2%+9.5%-10.0%
Q3 2020-5.5%-4.2%+2.4%
Q2 2020-11.2%-14.9%-14.6%
Q1 2020-3.6%-2.3%+14.4%
Q4 2019-5.8%+2.5%-6.7%
Q3 2019-7.0%-3.5%+1.0%
Q2 2019-0.3%-1.2%-6.4%
Q1 2019-0.2%-0.8%-0.7%
Q4 2018-5.3%-1.7%+8.7%
Q3 2018-8.7%-7.0%-2.3%
Q2 2018+7.7%+10.4%+16.4%
Q1 2018-6.0%-0.6%+10.2%
Q4 2017-3.8%-8.9%-7.1%
Q3 2017-3.2%-0.7%+1.8%
Q2 2017+13.8%+11.9%+17.6%
Q1 2017+2.4%+2.6%-3.6%
Q4 2016+1.4%+1.8%+5.3%
Q3 2016-0.4%-1.1%-6.2%
Q2 2016+7.7%+10.4%+12.5%
Q1 2016-0.7%
Q4 2015-6.0%
Q3 2015-5.0%
Q2 2015-9.4%
Q1 2015-1.6%
Q4 2014-1.9%
Q3 2014+8.9%
Q2 2014-2.6%
Q1 2014+8.8%
Q4 2013+4.6%
Q3 2013+10.6%
Q2 2013+9.1%
Q1 2013+11.3%
Q4 2012-3.6%
Q3 2012-1.1%
Q2 2012-2.7%
Q1 2012-1.9%
Q1 2011-3.5%
Q4 2011-4.1%
Q4 2008-4.1%
Q3 2010+2.2%
Q3 2011+2.2%
Q2 2010+3.6%
Q2 2011+3.6%
Q4 2010+3.6%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro